31. Overprescribing in the spotlight. Issue 1 (22nd January 2019) Authors: Payne, Rupert Journal: Prescriber Issue: Volume 30:Issue 1(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Pitfalls of prescribing suitably for athletes. Issue 8 (12th September 2016) Authors: Payne, Rupert Journal: Prescriber Issue: Volume 27:Issue 8(2016:Aug.) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Plans, partnerships, pacts and prescribing. Issue 2 (20th February 2019) Authors: Payne, Rupert Journal: Prescriber Issue: Volume 30:Issue 2(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Polypharmacy – appropriate, problematic or both?. Issue 4 (19th February 2015) Authors: Payne, Rupert; Duerden, Martin Journal: Prescriber Issue: Volume 26:Issue 4(2015:Feb.) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Polypharmacy – what is it and how common is it?. Issue 21 (5th November 2014) Authors: Duerden, Martin; Payne, Rupert Journal: Prescriber Issue: Volume 25:Issue 21(2014:Nov.) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Regular review is needed for medicines optimisation. Issue 6 (19th March 2015) Authors: Duerden, Martin; Payne, Rupert Journal: Prescriber Issue: Volume 26:Issue 6(2015:Mar.) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK. Issue 12 (4th December 2017) Authors: Doble, Brett; Payne, Rupert; Harshfield, Amelia; Wilson, Edward C F Journal: BMJ open Issue: Volume 7:Issue 12(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. SHORT-TERM SAFETY OF ANTIHYPERTENSIVE MEDICATION REDUCTION IN MULTI-MORBID PATIENTS WITH MILD HYPERTENSION: THE OPTIMISE RANDOMISED CONTROLLED NON-INFERIORITY TRIAL. (April 2021) Authors: Sheppard, James; Burt, Jenni; Lown, Mark; Temple, Eleanor; Lowe, Rebecca; Fraser, Rosalyn; Allen, Julie; Ford, Gary; Heneghan, Carl; Hobbs, Richard; Jowett, Sue; Kodabuckus, Shahela; Little, Paul; Mant, Jonathan; Mollison, Jill; Payne, Rupert; Williams, Marney; Yu, Ly-Mee; McManus, Richard Journal: Journal of hypertension Issue: Volume 39(2021)e-Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Sustainable medicines development and use: Our collective responsibility for action to mitigate the natural world crisis. Issue 7 (6th September 2021) Authors: Fisk, Marie; Zecharia, Anna; Payne, Rupert; Okorie, Michael; Alexander, Stephen; Baker, Emma; Cremers, Serge Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 7(2022) Page Start: 3013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. The barriers around antibiotic development. Issue 10 (19th October 2018) Authors: Payne, Rupert Journal: Prescriber Issue: Volume 29:Issue 10(2018) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗